Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions

(2017) Eugene Y. Chiang et al.   Nature Communications

Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism

(2015) Hiroko Miyadera et al.   JOURNAL OF HUMAN GENETICS

Clinical improvement in psoriasis with specific targeting of interleukin-23

(2015) Tamara Kopp et al.   NATURE

Resident memory T cells in human health and disease

(2015) R. A. Clark   Science Translational Medicine

Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases

(2015) Yipeng Zhao et al.   Toxins

Psoriasis prevalence among adults in the United States

(2014) Tara D. Rachakonda et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The CNS under pathophysiologic attack—examining the role of K2P channels

(2014) Petra Ehling et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Combined Use of Systemic Agents for Psoriasis

(2014) Celine Busard et al.   JAMA Dermatology

Systematic Review of UV-Based Therapy for Psoriasis

(2013) Fahad Almutawa et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review

(2013) Ashley L. Semble et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T-cell-mediated skin diseases

(2013) Marta Ferran et al.   EXPERIMENTAL DERMATOLOGY

Autoimmune effector memory T cells: the bad and the good

(2013) Priyadharshini Devarajan et al.   IMMUNOLOGIC RESEARCH

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses

(2013) Michelle A. Lowes et al.   TRENDS IN IMMUNOLOGY

Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States

(2013) April W. Armstrong et al.   JAMA Dermatology

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

(2013) Henrik Boye Jensen et al.   Therapeutic Advances in Neurological Disorders

Clinical overview of the seizure risk of dalfampridine

(2012) Sheryl R. Haut et al.   Expert Opinion On Drug Safety

Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis

(2012) A. R. Gocke et al.   JOURNAL OF IMMUNOLOGY

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases

(2011) Victor Chi et al.   TOXICON

Alefacept: where it stands today

(2010) Jinan Chaarani et al.   Expert Opinion on Drug Metabolism & Toxicology

Physiological Basis of Tingling Paresthesia Evokedby Hydroxy- -Sanshool

(2010) R. C. Lennertz et al.   JOURNAL OF NEUROSCIENCE

How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review

(2009) Phyllis I. Spuls et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Participation of Kv1 Channels in Control of Membrane Excitability and Burst Generation in Mesencephalic V Neurons

(2009) Chie-Fang Hsiao et al.   JOURNAL OF NEUROPHYSIOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2009) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

CD40 and autoimmunity: The dark side of a great activator

(2009) Anna L. Peters et al.   SEMINARS IN IMMUNOLOGY

Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block

(2008) Melanie P. Matheu et al.   IMMUNITY

Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels

(2008) Diana M Bautista et al.   NATURE NEUROSCIENCE